BRAINTREE, Mass., May 8, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year ended March 31, 2018 are available on its Investor relations website.
The Company is posting this press release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website.
Direct link to Earnings Release 4Q and FY18:
Direct link to Results Tables 4Q and FY18 That Will Be Referenced on Webcast:
As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on May 8, 2018. The call can be accessed with the following information:
- U.S. / Canada toll free (877) 848-8880; International (716) 335-9513 Conference ID required for access: 4077509.
- A live webcast of the call can be accessed on Haemonetics' investor relations website.
Direct link to Conference Call Webcast https://edge.media-server.com/m6/p/wcre57f8.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
Investor Contact |
Media Contact |
Gerry Gould, VP-Investor Relations |
Carla Burigatto, VP-Communications |
(781) 356-9402 |
(781) 348-7263 |
SOURCE Haemonetics Corporation
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article